Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

SHE:000623 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 20, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	22,170	20,653	17,098	17,020	21,034	18,957
Market Cap Growth	6.24%	20.79%	0.46%	-19.09%	10.96%	-1.39%
Enterprise Value	21,556	20,126	16,961	17,193	19,596	17,652
Last Close Price	18.91	16.80	13.91	13.52	16.33	14.37
PE Ratio	8.68	13.31	11.71	9.56	11.81	11.09
PS Ratio	9.47	7.91	4.96	5.93	9.13	8.42
PB Ratio	0.72	0.71	0.62	0.65	0.84	0.81
P/TBV Ratio	0.74	0.72	0.64	0.66	0.86	0.82
P/FCF Ratio	172.18	-	-	111.32	1821.95	116.28
P/OCF Ratio	82.91	347.21	251.22	40.15	64.75	48.56
EV/Sales Ratio	9.21	7.71	4.92	5.99	8.51	7.84
EV/EBITDA Ratio	257.14	442.54	49.91	52.66	97.79	136.07
EV/EBIT Ratio	-	-	126.08	132.35	3339.39	-
EV/FCF Ratio	167.42	-	-	112.45	1697.40	108.28
Debt / Equity Ratio	0.07	0.08	0.11	0.11	0.10	0.11
Debt / EBITDA Ratio	26.80	31.37	8.23	8.41	12.45	19.13
Debt / FCF Ratio	17.45	-	-	19.56	226.58	15.22
Asset Turnover	0.07	0.08	0.11	0.10	0.08	0.09
Inventory Turnover	1.39	1.77	2.02	1.93	1.95	1.70
Quick Ratio	1.76	1.57	1.08	2.25	3.89	4.01
Current Ratio	2.14	1.96	1.29	2.70	4.35	4.47
Return on Equity (ROE)	8.51%	5.35%	5.37%	7.01%	7.29%	7.36%
Return on Assets (ROA)	-0.28%	-0.31%	0.27%	0.27%	0.01%	-0.15%
Return on Capital (ROIC)	-0.29%	-0.32%	0.28%	0.29%	0.01%	-0.16%
Return on Capital Employed (ROCE)	-0.50%	-0.50%	0.50%	0.40%	0.00%	-0.30%
Earnings Yield	11.58%	7.51%	8.54%	10.46%	8.46%	9.01%
FCF Yield	0.58%	-1.04%	-2.06%	0.90%	0.06%	0.86%
Dividend Yield	3.17%	2.98%	4.31%	2.22%	1.84%	1.39%
Payout Ratio	25.49%	68.33%	27.44%	21.21%	14.36%	14.76%
Buyback Yield / Dilution	7.34%	9.08%	0.46%	-3.36%	1.39%	0.28%
Total Shareholder Return	10.51%	12.06%	4.77%	-1.14%	3.22%	1.67%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.